|
Market Closed -
Saudi Arabian S.E.
09:49:56 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 64.15 SAR | +0.47% |
|
+1.58% | +0.96% |
| 10-07 | Avalon Pharma, Aurisco to Cooperate on Oligonucleotide Manufacturing in Saudi Arabia | MT |
| 09-17 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
Chart: Technical Analysis
Saudi Arabian S.E.SAR
| Markets | Quality | ||
|---|---|---|---|
Saudi Arabian S.E.
| 4016 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Neutral |
| Resistance | 65.3 | 68 | 78.4 |
| Spread/Res. | -1.76% | -5.66% | -18.18% |
| Spread/Supp. | +3.89% | +3.89% | +15.50% |
| Support | 61.75 | 61.75 | 55.54 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4016 Stock
- Charts Middle East Pharmaceutical Industries Company
Select your edition
All financial news and data tailored to specific country editions
